行情

ATOS

ATOS

Atossa Genetics
NASDAQ

实时行情|Nasdaq Last Sale

1.770
-0.060
-3.28%
盘后: 1.740 -0.03 -1.69% 16:17 10/17 EDT
开盘
1.820
昨收
1.830
最高
1.820
最低
1.690
成交量
14.54万
成交额
--
52周最高
7.39
52周最低
0.8000
市值
1,615.93万
市盈率(TTM)
-0.7315
分时
5日
1月
3月
1年
5年

分析师评级

1位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

ATOS 新闻

  • 沙特阿美:IPO时机将取决于市场条件和股东
  • 新浪财经.2小时前
  • 如何投资红利ETF:耐心比择时更重要么?
  • 新浪财经.2小时前
  • 易纲会见美联储主席鲍威尔 交换了对货币政策等看法
  • 央行.2小时前
  • 日本预计美日贸易协定将使日本GDP增加0.8%
  • 新浪财经.3小时前

更多

所属板块

先进医疗设备和技术
+0.26%
医疗设备和用品
+0.66%

热门股票

名称
价格
涨跌幅

ATOS 简况

Atossa Genetics Inc. is a clinical-stage pharmaceutical company focused on the development of therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. The Company's leading program uses its intraductal microcatheters, which deliver pharmaceuticals through the breast ducts. It has initiated a Phase II clinical study using its microcatheters to deliver fulvestrant as a treatment of ductal carcinoma in-situ (DCIS) and breast cancer. Its second pharmaceutical program under development is Afimoxifene Topical Gel (AfTG) for the treatment and prevention of hyperplasia of the breast. It is also engaged in the process of evaluating other therapeutic candidates to treat other breast conditions, including breast cancer. Its medical devices include the ForeCYTE Breast Aspirator and the FullCYTE Breast Aspirator. These devices are intended for the collection of nipple aspirate fluid (NAF) for cytological testing at a laboratory.
展开

Webull提供Atossa Genetics Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。